Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Podoloff

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancerP Bassa, E E Kim, T Inoue, et al.
Cancer|February 1, 1994
Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patientsJ L Murray, M G Rosenblum, H Z Zhang, et al.
Nuclear Medicine Communications|July 1, 1996
99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical managementR Sirisriro, D A Podoloff, Y Z Patt, et al.
Journal of Drug Targeting|January 1, 1996
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]IodoerythronitroimidazoleA Cherif, S Wallace, D J Yang, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Assessment of tumor cell proliferation using [18F]fluorodeoxyadenosine and[18F]fluoroethyluracilC G Kim, D J Yang, E E Kim, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 11, 1992
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PETE E Kim, S K Chung, T P Haynie, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trialD J Macey, E J Grant, L Kasi, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaG A Wiseman, C A White, R B Sparks, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancerP Bassa, E E Kim, T Inoue, et al.
Cancer|February 1, 1994
Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patientsJ L Murray, M G Rosenblum, H Z Zhang, et al.
Nuclear Medicine Communications|July 1, 1996
99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical managementR Sirisriro, D A Podoloff, Y Z Patt, et al.
Journal of Drug Targeting|January 1, 1996
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]IodoerythronitroimidazoleA Cherif, S Wallace, D J Yang, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Assessment of tumor cell proliferation using [18F]fluorodeoxyadenosine and[18F]fluoroethyluracilC G Kim, D J Yang, E E Kim, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 11, 1992
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PETE E Kim, S K Chung, T P Haynie, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trialD J Macey, E J Grant, L Kasi, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaG A Wiseman, C A White, R B Sparks, et al.
Pageof 7